A sensitive assay for measuring whole-blood responses to type I IFNs

Proc Natl Acad Sci U S A. 2024 Oct;121(40):e2402983121. doi: 10.1073/pnas.2402983121. Epub 2024 Sep 23.

Abstract

Human inborn errors of the type I IFN response pathway and auto-Abs neutralizing IFN-α, -β, and/or -ω can underlie severe viral illnesses. We report a simple assay for the detection of both types of condition. We stimulate whole blood from healthy individuals and patients with either inborn errors of type I IFN immunity or auto-Abs against type I IFNs with glycosylated human IFN-α2, -β, or -ω. As controls, we add a monoclonal antibody (mAb) blocking the type I IFN receptors and stimulated blood with IFN-γ (type II IFN). Of the molecules we test, IP-10 (encoded by the interferon-stimulated gene (ISG) CXCL10) is the molecule most strongly induced by type I and type II IFNs in the whole blood of healthy donors in an ELISA-like assay. In patients with inherited IFNAR1, IFNAR2, TYK2, or IRF9 deficiency, IP-10 is induced only by IFN-γ, whereas, in those with auto-Abs neutralizing specific type I IFNs, IP-10 is also induced by the type I IFNs not neutralized by the auto-Abs. The measurement of type I and type II IFN-dependent IP-10 induction therefore constitutes a simple procedure for detecting rare inborn errors of the type I IFN response pathway and more common auto-Abs neutralizing type I IFNs.

Keywords: ELISA; IP-10; auto-antibodies; diagnostic test; type I interferons.

MeSH terms

  • Chemokine CXCL10* / blood
  • Enzyme-Linked Immunosorbent Assay / methods
  • Humans
  • Interferon Type I* / immunology
  • Interferon-gamma / blood
  • Interferon-gamma / immunology
  • Receptor, Interferon alpha-beta / genetics

Substances

  • Interferon Type I
  • Chemokine CXCL10
  • CXCL10 protein, human
  • Receptor, Interferon alpha-beta
  • Interferon-gamma

Grants and funding